SCHEMBL22296434

SCHEMBL22296434

Cc1cc(C(F)F)ccc1-c1ccc2c(cnn2C(CC(C)C)c2ccc(C(=O)NCCC(=O)O)nc2)c1

nearest known ligand 0.74

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GCGR P47871 20/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19922100 0.92 GCGR (0.74) GCGR
SCHEMBL19922079 0.92 GCGR (0.88) GCGR
SCHEMBL19922240 0.87 GCGR (0.82) GCGR
SCHEMBL19922111 0.85 GCGR (0.85) GCGR
SCHEMBL19922194 0.85 GCGR (1.00) GCGR
SCHEMBL19922176 0.84 GCGR (0.82) GCGR
SCHEMBL19922108 0.83 GCGR (0.82) GCGR
SCHEMBL20273108 0.83 GCGR (0.61) GCGR
SCHEMBL19922241 0.83 GCGR (0.79) GCGR
SCHEMBL19922192 0.82 GCGR (1.00) GCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3510026-B1 INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2020-08-12 EP disclosed
EP-3510028-B1 INDAZOLE DERIVATIVES USEFUL AS GLUCAGON RECEPTOR ANTAGONISTS JANSSEN PHARMACEUTICA NV (BE) 2020-08-05 EP disclosed